Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Gary Charles Robb, Chief Business Officer of Corcept Therapeutics Inc, sold 10,000 shares of common stock on August 17, 2026 for $116.26 per share.
Summary
- Bona fide gift: disposed of 125 Common Stock on August 17, 2026; holds 13,426 after (Direct).
- Open-market sale: disposed of 10,000 Common Stock at $116.26 ($1,162,572) on August 17, 2026; holds 39,716 after (Indirect).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,162,572 of stock on the open market.
Insider Transactions
Gary Charles Robb — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Bona fide gift | Common Stock | 125 | — | — | 13,426 |
| 2026-08-17 | Open-market sale | Common Stock | 10,000 | $116 | $1.2M | 39,716 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Bona fide gift (125 shares) |
| 2026-08-17 | Open-market sale (10,000 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Gary Charles Robb
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.